Alzheimer’s
Earnings Update: Second GW Pharmaceuticals Stock Price Increase After February’s Alzheimer’s Trial News
GW Pharmaceuticals (NASDAQ: GWPH) has been on a tear over the past month after exceeding expectations with its Q4 results, which were…